alix: let's go to the next story, fresenius dropping the akorn bid.o important in the industry. >> this is an interesting situation. fresenius has come out and said there is something really wrong in the way that akorn was reporting drug data to the fda -- saying that is reason enough for them to break up the merger. we do not know exactly what they found. they put out a very brief statement that there was something not quite right. akorn hit back and said they would fight to get this done. a fresenius can prove there is something called a material adverse change, they will be able to walk. but no current party has ever proven that material adverse change has happened. what will likely happen is akorn will re-cut the price. there was a similar deal last sound also one side the things they did not like, but they still have to go through the deal. david: does akorn have any choice but to fight this? if theyom the deal, have been lying to the fda, that is a big problem. ed: and they have other problems. the chairman was caught up in a racketeering probe,

investigation, but was turned down, interestingly, investors have become ready wary about this deal since fresenius it a year ago. the former chairman left the company after being arrested on separate racketeering charges. shares little changed on the day. that's a look at european markets. theie: in u.s. markets, dollar index has come bounding back. we are right back up toward 91 now on the dollar index and that is causing some currencies to weaken, including the yen well above 1.0 -- 108.50. i thought it was interesting to --ch the -- we can as well weaken as well. as we are going to be telling you all day until we reached the 3%, we will be watching the 10 year yield. , global macrogmm movers. the australian is moving, at the weakest for the year. weaker by another .8%, liquidating the -- the main reason for this, there's a short position building. you can see the bloomberg dollar index that gets to broad backed currencies. also sharpening -- rising sharply today. the idea the russian sanctions penalizing -- weas have aluminum down and steel down 1.1 percent and gold down another percentage poin

fresenius has pulled out of its access of akorn. they said it found material data breaches at the company. the german health care group had agreed to buy akorn for $4.7 billion but it said it could terminate the deal following the outcome of its own independent investigation. whitbread split is they cite anonymous sources saying that they had pushed whitbread to help them value it. shares in philips are at a slight rise. they boosted earning ebida came into earnings amortization came in at 263 million euros topping expectations. >>> speaking out here on the show, the chief executive frans van houten speaking out. >> 10% earnings growth thanks to many new earnings growth across diagnosis, treatment, we saw strong traction in the market. customers are rewarding that we have eight new large-scale customer deals in. so all over it was a good start of the year, indeed. >>> u.s. president donald trump has struck a more cautious thought on north korea he wrote on twitter till a long way to go before the two countries could reach any kind o

fresenius terminating a deal to buy akorn. they say they didn't meet several closing conditions and an investigation showed fda problems. >>> we are just getting started here on "worldwide exchange. up next, we are putting asia up front and center comments from the bank of japan. what he said about monetary policy >>> later, live on the korean pe ni peninsula, north korea vowing to stop their nuclear program we're finally back out in our yard, but so are they. introducing scotts turf builder triple action. it kills weeds, prevents crabgrass and feeds so grass can thrive, guaranteed. our backyard is back. this is a scotts yard. you know what's not awesome? gig-speed internet. when only certain people can get it. let's fix that. let's give this guy gig- really? and these kids, and these guys, him, ah. oh hello. that lady, these houses! yes, yes and yes. and don't forget about them. uh huh, sure. still yes! xfinity delivers gig speed to more homes than anyone. now you can get it, too. welcome to the party. >>> 5:12 here on the ea

i'm looking at fresenius. found breaches of fda data integrity standards in the target company, and you what? investors have become increasingly wary of this potential deal since it announced that a year ago. they are pushing the shares to their highest since the end of february. ]ubs dropping the most in a month. estimates.it beat equities revenue increased on high volatility in the first quarter. other businesses did less well. the key wealth management unit probably explains why we are seeing the shares fall today. back. guy. -- matt, guy. matt: still with us is freddie lait. freddie, i want to ask you about offsson's knocking the ball -- knocking the cover off the ball last week. the stock was insane in the huge jump we saw. we hold nokia, kpn, tdc. what does this mean for the whole sector? freddie: the results were fantastic last week. i hope nokia follows suit this week. the sector as a whole is in a positive position in my mind, but it has a valuation discount because there is no real catalyst purity wi

fresenius is under pressure down 4%. >>> we have a deal in the tech care center. dental solutions henry schein spinning off its animal health business to merge with privately held vet first choice they're creating an independent company. here we have harry schein ceo. the new company will be called vets first congratulations. before we get into it, help us understand what you were thinking in terms of deciding for whatever reason that you thought that the dental world needed to live on one side of the world and the pets business on a different side though i always thought you needed to take care of all of the pets teeth. >> we are going to take care of the pets teeth that's not the question. this is one of the most exciting transactions i've ever seen in my period in health care we are -- it's all about growth and it's all about unlocking shareholder value. we're going to be in a position now to vie for both the medical and dental part of henry schein focused on wellness and prevention focusing on its own customers and the animal health side focusing on its custom